There are 2789 resources available
916P - Impact of sarcopenia (S) on efficacy and toxicity of nivolumab (N) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
Presenter: Leonardo Muratori
Session: ePoster Display
917P - Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial
Presenter: Anna Finger
Session: ePoster Display
798P - A phase II study of pembrolizumab (P) in combination with doxorubicin (D) in advanced endometrial cancer (AEC): TOPIC trial/VHIO10001
Presenter: Lorena Fariñas-Madrid
Session: ePoster Display
1057P - ROS1 mutation can serve- as a potential efficacious predictor of immunotherapy in melanoma patients
Presenter: Hucheng Liu
Session: ePoster Display
966P - Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy
Presenter: Alessio Cortellini
Session: ePoster Display
967P - The time of anti-PD-1 infusion improves survival outcomes by fasting conditions simulation in non-small cell lung cancer
Presenter: Anna Vilalta
Session: ePoster Display
968P - Association between use of antibiotics (ATB) and clinical outcomes with tislelizumab (tisle) monotherapy
Presenter: Zheng-Gang Ren
Session: ePoster Display
969P - Effect of angiotensin II inhibition on non-small cell lung cancer response to immune checkpoint blockers
Presenter: Patricia Pereira
Session: ePoster Display
970P - Assessment of anti-PD-1 antibody and immune complex binding to Fcγ receptors and clinical implications
Presenter: Elena Daveri
Session: ePoster Display
1061P - Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme
Presenter: Almudena Garcia Castano
Session: ePoster Display
Resources:
Abstract